Receptor-receptor interactions: A novel concept in brain integration

Progress in Neurobiology

Volumn 90, Issue 2, 2010, Pages 157-175

  Agnati, Luigi F ^a   Guidolin, Diego ^b   Leo, Giuseppina ^a   Carone, Chiara ^a   Genedani, Susanna ^a   Fuxe, Kjell ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Allosterism; Atomic Force Microscopy; Homocysteine; Parkinson's Disease; Receptor mosaic

Indexed keywords

ADENOSINE A2A RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HOMOCYSTEINE; LEVODOPA; MORPHINE; NEUROLEPTIC AGENT; OPIATE RECEPTOR; QUINPIROLE;

ALLOSTERISM; ANALGESIA; ATOMIC FORCE MICROSCOPY; BRAIN FUNCTION; CELL MEMBRANE; CONFOCAL LASER MICROSCOPY; CONFORMATIONAL TRANSITION; DOPAMINERGIC TRANSMISSION; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; HYPERHOMOCYSTEINEMIA; LEARNING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MORPHINE TOLERANCE; NERVE CELL NETWORK; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; SHORT TERM MEMORY; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ALLOSTERIC REGULATION; ANIMALS; BINDING SITES; BRAIN; CELL MEMBRANE; HOMOCYSTEINE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ATOMIC FORCE; MODELS, BIOLOGICAL; RECEPTOR, ADENOSINE A2A; RECEPTORS, CELL SURFACE; RECEPTORS, DOPAMINE;

EID: 76849085436     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2009.10.004     Document Type: Review

References (105)

1. Agnati L.F., Ferré S., Burioni R., Woods A., Genedani S., Franco R., and Fuxe K. Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases. Neuromol. Med. 7 1-2 (2005) 61-78
2. Agnati L.F., Ferré S., Genedani S., Leo G., Guidolin D., Filaferro M., Carriba P., Casadó V., Lluis C., Franco R., Woods A.S., and Fuxe K. Allosteric modulation of dopamine D2 receptors by homocysteine. J. Proteome Res. 5 11 (2006) 3077-3083
3. Agnati L.F., Ferré S., Leo G., Lluis C., Canela E., Franco R., and Fuxe K. On the molecular basis of the receptor mosaic hypothesis of the engram. Cell Mol. Neurobiol. 24 4 (2004) 501-516
4. Agnati L.F., Ferré S., Lluis C., Franco R., and Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55 (2003) 509-550
5. Agnati L.F., Franzen O., Ferré S., Leo G., Franco R., and Fuxe K. Possible role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia. J. Neural. Transm. Suppl. 65 (2003) 1-28
6. Agnati L.F., and Fuxe K. Subcortical limbic 3H-N-propylnorapomorphine binding sites are markedly modulated by cholecystokinin-8 in vitro. Biosci. Rep. 3 12 (1983) 1101-1105
7. Agnati L.F., and Fuxe K. New concepts on the structure of the neuronal networks: the miniaturization and hierarchical organization of the central nervous system (hypothesis). Biosci. Rep. 4 2 (1984) 93-98
8. Agnati L.F., and Fuxe K. Volume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing's B-type machine. Prog. Brain Res. 125 (2000) 3-19
9. Agnati L.F., Fuxe K., and Ferré S. How receptor mosaics decode transmitter signals. Possible relevance of cooperativity. Trends Biochem. Sci. 30 4 (2005) 188-193
10. Agnati, L.F., Fuxe, K., Nicholson, C., Sykova, E., 2000. Volume Transmission Revisited. Progress in Brain Research 125, Elsevier, Amsterdam.
11. Agnati L.F., Fuxe K., Zini I., Lenzi P., and Hökfelt T. Aspects on receptor regulation and isoreceptor identification. Med. Biol. 58 (1980) 182-187
12. Agnati L.F., Fuxe K., Zoli M., Rondinini C., and Ogren S.O. New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram. Med. Biol. 60 4 (1982) 183-190
13. Agnati L.F., Fuxe K., Zoli M., Ozini I., Toffano G., and Ferraguti F. A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission. Acta Physiol. Scand. 128 (1986) 201-207
14. Agnati L.F., Guidolin D., Carone C., Dam M., Genedani S., and Fuxe K. Understanding neuronal molecular networks builds on neuronal cellular network architecture. Brain Res. Rev. 58 2 (2008) 379-399
15. Agnati L.F., Guidolin D., Genedani S., Ferré S., Bigiani A., Woods A.S., and Fuxe K. How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics. J. Mol. Neurosci. 26 2-3 (2005) 133-154
16. Agnati L.F., Guidolin D., Leo G., and Fuxe K. A Boolean network modelling of receptor mosaics relevance of topology and cooperativity. J. Neural. Transm. 114 1 (2007) 77-92
17. Agnati L.F., Guidolin D., Leo G., Genedani S., Arhem P., Forni A., Andreoli N., and Fuxe K. Role of cooperativity in protein folding and protein mosaic assemblage relevance for protein conformational diseases. Curr. Protein Pept. Sci. 8 5 (2007) 460-470
18. Agnati L.F., Leo G., Genedani S., Andreoli N., Marcellino D., Woods A., Piron L., Guidolin D., and Fuxe K. Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains. Brain Res. Rev. 58 2 (2008) 459-474
19. Agnati L.F., Leo G., Zanardi A., Genedani S., Rivera A., Fuxe K., and Guidolin D. Volume transmission and wiring transmission from cellular to molecular networks: history and perspectives. Acta Physiol. 187 1-2 (2006) 329-344
20. Agnati L.F., Santarossa L., Benfenati F., Ferri M., Morpurgo A., Apolloni B., and Fuxe K. Molecular basis of learning and memory: modelling based on receptor mosaics. In: Apolloni B., and Kurfes F. (Eds). From Synapses to Rules (2002), Kluwer Academic/Plenum Publishers, New York 165-196
21. Agnati L.F., Santarossa L., Genedani S., Canela E., Leo G., Franco R., and Fuxe K. On the nested hierarchical organization of CNS: basic characteristics of neuronal molecular networks. In: Erdi P., Esposito A., Marinaro M., and Scarpette S. (Eds). Computational Neuroscience: Cortical Dynamics. Lecture Notes in Computer Science (2004), Springer, Berlin/Heidelberg/New York 24-54
22. Agnati L.F., Tarakanov A.O., Ferré S., Fuxe K., and Guidolin D. Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implications for drug development. J. Mol. Neurosci. 26 2-3 (2005) 193-208
23. Agnati L.F., Zoli M., Grimaldi R., Fuxe K., Toffano G., and Zini I. Cellular and synaptic alterations in the aging brain. Aging (Milano) 2 1 (1990) 5-25
24. Angers S., Salahpour A., and Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 409-435
25. Bjelke B., Goldstein M., Tinner B., Andersson C., Sesack S., Steinbusch H., and Lew J. Dopaminergic transmission in the rat retina: evidence for volume transmission. J. Chem. Neuroanat. 12 (1996) 37-50
26. Breedlove S.M., Rosenzweig M.R., and Watson N.V. Biological Psychology (2007), Sinauer Associates, Inc., Sunderland, MA
27. Bulenger S., Marullo S., and Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 26 3 (2005) 131-137
28. Carlsson A., and Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharm. Toxicol. (Copenh.) 120 (1963) 140-144
29. Carpenter K.J., Sen S., Matthews E.A., Flatters S.L., Wozniak K.M., Slusher B.S., and Dickenson A.H. Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat. Neuropeptides 37 5 (2003) 298-303
30. Changeux J.P., and Edelstein S.J. Allosteric mechanisms of signal transduction. Science 308 5727 (2005) 1424-1428
31. Cowan N. On short and long auditory stores. Psychol. Bull. 96 (1984) 341-370
32. Cowan W.M., Harter D.H., and Kandel E.R. The emergence of modern neuroscience: some implications for neurology and psychiatry. Annu. Rev. Neurosci. 23 (2000) 343-391
33. Del Giudice P., Fusi S., and Matti M. Modelling the formation of working memory with networks of integrate-and-fire neurons connected by plastic synapses. J. Physiol. 97 (2003) 659-681
34. Del Sol A., Araúzo-Bravo M.J., Amoros D., and Nussinov R. Modular architecture of protein structures and allosteric communications: potential implications for signaling proteins and regulatory linkages. Genome Biol. 8 5 (2007) R92
35. Del Sol A., and Carbonell P. The modular organization of domain structures: insights into protein-protein binding. PLoS Comput. Biol. 3 12 (2007) e239
36. Dyson H.J., and Wright P.E. According to current textbooks, a well-defined three-dimensional structure is a prerequisite for the function of a protein. Is this correct?. IUBMB Life 58 2 (2006) 107-109
37. Fenton A.W. Allostery: an illustrated definition for the 'second secret of life'. Trends Biochem. Sci. 33 9 (2008) 420-425
38. Ferré S., Ciruela F., Canals M., Marcellino D., Burgueno J., Casadó V., Hillion J., Torvinen M., Fanelli F., Benedetti P., Goldberg S.R., Bouvier M., Fuxe K., Agnati L.F., Lluis C., Franco R., and Woods A. Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism Relat. Disord. 10 5 (2004) 265-271
39. Ferré S., Fredholm B.B., Morelli M., Popoli P., and Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20 10 (1997) 482-487
40. Ferré S., Fuxe K., von Euler G., Johansson B., and Fredholm B.B. Adenosine-dopamine interactions in the brain. Neuroscience 51 3 (1992) 501-512
41. Ferré S., Herrera-Marschitz M., Grabowska-Andén M., Casa M., Ungerstedt U., and Andén N.E. Postsynaptic dopamine/adenosine interaction. I. Adenosine analogues inhibit dopamine D 2-mediated behaviour in short-term reserpinized mice. Eur. J. Pharmacol. 192 (1991) 25-29
42. Ferré S., von Euler G., Johansson B., Fredholm B.B., and Fuxe K. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. U.S.A. 88 16 (1991) 7238-7241
43. Franco R., Casadó V., Cortés A., Ferrada C., Mallol J., Woods A., Lluis C., Canela E., and Ferré S. Basic concepts in G-protein-coupled receptor homo- and heterodimerization. Sci. World J. 7 (2007) 48-57
44. Franco R., Ferré S., Agnati L., Torvinen M., Ginés S., Hillion J., Casadó V., Lledó P., Zoli M., Lluis C., and Fuxe K. Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology 23 4 Suppl. (2000) S50-59
45. Frey U., and Morris R.G. Synaptic tagging and long-term potentiation. Nature 385 6616 (1997) 533-536
46. Fuxe K., and Agnati L.F. Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses. Med. Res. Rev. 5 4 (1985) 441-482
47. Fuxe K., and Agnati L.F. Opening address. In: Fuxe K., and Agnati L.F. (Eds). Receptor-Receptor Interactions. A New Intramembrane Integrative Mechanism (1987), MacMillan, London 14-18
48. Fuxe K., Agnati L.F., Härfstrand A., Zoli M., von Euler G., Grimaldi R., Merlo Pich E., Bjelke B., Eneroth P., and Benfenati F. On the role of neuropeptide Y in information handling in the central nervous system in normal and physiopathological states. Focus on volume transmission and neuropeptide Y/alpha 2 receptor interactions. Ann. N. Y. Acad. Sci. 579 (1990) 28-67
49. Fuxe K., Agnati L.F., Jacobsen K., Hillion J., Canals M., Torvinen M., Tinner-Staines B., Staines W., Rosin D., Terasmaa A., Popoli P., Leo G., Vergoni V., Lluis C., Ciruela F., Franco R., and Ferré S. Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology 61 11 Suppl. 6 (2003) S19-23
50. Fuxe K., Agnati L.F., von Euler G., Tanganelli S., O'Connor W.T., Ferré S., Hedlund P., and Zoli M. Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophrenia. Neurochem. Int. 20 Suppl. (1992) 215S-224S
51. Fuxe K., Ferré S., Canals M., Torvinen M., Terasmaa A., Marcellino D., Goldberg S.R., Staines W., Jacobsen K.X., Lluis C., Woods A.S., Agnati L.F., and Franco R. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J. Mol. Neurosci. 26 2-3 (2005) 209-220
52. Fuxe K., Ferré S., Genedani S., Franco R., and Agnati L.F. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol. Behav. 92 1-2 (2007) 210-217
53. Fuxe K., Ferré S., Zoli M., and Agnati L.F. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res. Brain Res. Rev. 26 2-3 (1998) 258-273
54. Fuxe K., Marcellino D., Genedani S., and Agnati L. Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease. Mov. Disord. 22 14 (2007) 1990-2017
55. Fuxe K., Marcellino D., Rivera A., Diaz-Cabiale Z., Filip M., Gago B., Roberts D.C., Langel U., Genedani S., Ferraro L., de la Calle A., Narvaez J., Manganelli S., Woods A., and Agnati L.F. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res. Rev. 58 2 (2008) 415-452
56. Fuxe K., Strömberg I., Popoli P., Rimondini-Giorgini R., Torvinen M., Ogren S.O., Franco R., Agnati L.F., and Ferré S. Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum. Adv. Neurol. 86 (2001) 345-353
57. Fuxe K., von Euler G., van der Ploeg I., Fredholm B.B., and Agnati L.F. Pertussis toxin treatment counteracts the cardiovascular effects of neuropeptide Y and clonidine in the awake unrestrained rat. Neurosci. Lett. 101 3 (1989) 337-341
58. Genedani S., Guidolin D., Leo G., Filaferro M., Torvinen M., Woods A.S., Fuxe K., Ferré S., and Agnati L.F. Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers. J. Mol. Neurosci. 6 2-3 (2005) 177-184
59. Goodey N.M., and Benkovic S.J. Allosteric regulation and catalysis emerge via a common route. Nat. Chem. Biol. 4 8 (2008) 474-482
60. Guidolin D., Fuxe K., Neri G., Nussdorfer G.G., and Agnati L.F. On the role of receptor-receptor interactions and volume transmission in learning and memory. Brain Res. Rev. 55 1 (2007) 119-133
61. Gunasekaran K., Ma B., and Nussinov R. Is allostery an intrinsic property of all dynamic proteins?. Proteins 57 3 (2004) 433-443
62. Guo W., Urizar E., Kralikova M., Mobarec J.C., Shi L., Filizola M., and Javitch J.A. Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J. 27 17 (2008) 2293-2304
63. Guo C., and Levine H. A thermodynamic model for receptor clustering. Biophys. J. 77 5 (1999) 2358-2365
64. Gurevich V.V., and Gurevich E.V. GPCR monomers and oligomers: it takes all kinds. Trends Neurosci. 31 2 (2008) 74-81
65. Harold F.M. Molecules into cells: specifying spatial architecture. Microbiol. Mol. Biol. Rev. 69 4 (2005) 544-564
66. Hebb D.O. The Organization of Behavior (1949), John Wiley, New York
67. Hilser V.J., and Thompson E.B. Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins. Proc. Natl. Acad. Sci. U.S.A. 104 20 (2007) 8311-8315
68. Ishii Y., Taniguchi Y., Iwaki M., and Yanagida T. Thermal fluctuations biased for directional motion in molecular motors. Biosystems 93 1-2 (2008) 34-38
69. Ji X.D., Stiles G.L., van Galen P.J., and Jacobson K.A. Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling. J. Recept. Res. 12 2 (1992) 149-169
70. Kandel E.R., Schwartz J.H., and Jessel T.M. Principles of Neural Science. fourth edition (2000), McGraw-Hill, New York
71. Kappler J., Baader S.L., Franken S., Pesheva P., Schilling K., Rauch U., and Gieselmann V. Tenascins are associated with lipid rafts isolated from mouse brain. Biochem. Biophys. Res. Commun. 294 3 (2002) 742-747
72. Kenakin T. Seven transmembrane receptors as nature's prototype allosteric protein: de-emphasizing the geography of binding. Mol. Pharmacol. 74 3 (2008) 541-543
73. LaBerge D. Sustained attention and apical dendrite activity in recurrent circuits. Brain Res. Rev. 50 (2005) 86-99
74. Levoye A., Dam J., Ayoub M.A., Guillaume J.L., and Jockers R. Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers. EMBO Rep. 7 11 (2006) 1094-1098
75. Lynch M.A. Long-term potentiation and memory. Physiol. Rev. 84 1 (2004) 87-136
76. Luisi P.L. Toward the engineering of minimal living cells. Anat. Rec. 268 3 (2002) 208-214
77. Luttrell L.M. Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors. Mol. Biotechnol. 39 3 (2008) 239-264
78. Malenka R.C., and Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 44 1 (2004) 5-21
79. Malenka R.C., and Nicoll R.A. Long-term potentiation-a decade of progress?. Science 285 5435 (1999) 1870-1874
80. Markowitsch H.J. Psychogenic amnesia. Neuroimage 20 Suppl. 1 (2003) S132-138
81. Manders E.M.M., Verbeek E.J., and Aten J.A. Measurement of colocalization of objects in dual-colour confocal images. J. Microsc. 169 (1993) 175-182
82. Matheron G. Randoms Sets and Integral Equation (1978), Wiley, New York
83. May L.T., Leach K., Sexton P.M., and Christopoulos A. Allosteric modulation of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 1-51
84. McCulloch W.S., and Pitts W.H. A logical calculus of the ideas immanent in nervous activity. Bull. Math. Biophys. 5 (1943) 115-133
85. Monod J. Chance and Necessity: An Essay on the Natural Philosophy of Modern Biology (1979), William Collins Sons & Co. Ltd., Glasgow
86. Milligan G. G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharmacol. 66 1 (2004) 1-7
87. Okamoto T., Schlegel A., Scherer P.E., and Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273 10 (1998) 5419-5422
88. Philimonenko A.A., Janacek J., and Hozak P. Statistical evaluation of colocalization patterns in immunogold labeling experiments. J. Struct. Biol. 132 (2000) 201-210
89. Prinster S.C., Hague C., and Hall R.A. Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57 3 (2005) 289-298
90. Ripley B.D. Tests for randomness for spatial point patterns. J. R. Stat. Soc. B41 (1979) 368-374
91. Rodbell M. The complex regulation of receptor-coupled G-proteins. Adv. Enzyme Regul. 37 (1997) 427-435
92. Rosenblatt F. The Perceptron: a probabilistic model for information storage and organization in the brain. Psychol. Rev. 65 (1958) 386-408
93. Rozenfeld R., Abul-Husn N.S., Gomez I., and Devi L.A. An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function. Sci. World J. 7 (2007) 64-73
94. Rumelhart, D.E., Hinton, G.E., Williams, R.J., 1986. Learning internal representations by error propagation. In: Rumelhart, D.E., McClelland, J.L., and the PDP Research Group (Eds.), Parallel distributed processing: exploration in the microstructure of cognition. Cambridge, MA. MIT Press. pp. 318-362.
95. Russell B., and Aloy P. Targeting and tinkering with interaction networks. Nat. Chem. Biol. 4 11 (2008) 666-673
96. Seeman P., and Schaus J.M. Dopamine receptors labelled by [3H]quinpirole. Eur. J. Pharmacol. 203 1 (1991) 105-109
97. Shoemaker B.A., Portman J.J., and Wolynes P.G. Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc. Natl. Acad. Sci. U.S.A. 97 16 (2000) 8868-8873
98. Tanzi E. I fatti e le induzioni nell'odierna istologia del sistema nervoso. Riv. Sper. Freniate. Med. Leg. Alienazioni. Ment. 19 (1893) 419-472
99. Torvinen M., Marcellino D., Canals M., Agnati L.F., Lluis C., Franco R., and Fuxe K. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes. Mol. Pharm. 67 2 (2005) 400-407
100. Tsai C.J., del Sol A., and Nussinov R. Allostery: absence of a change in shape does not imply that allostery is not at play. J. Mol. Biol. 378 1 (2008) 1-11
101. Von Linne, 1751. Philosophica Botanica. Stoccolma.
102. Yang S.N., Fior D.R., Hedlund P.B., Agnati L.F., and Fuxe K. Antagonistic regulation of alpha 2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii. Eur. J. Pharmacol. 271 1 (1994) 201-212
103. Zaccai G. How soft is a protein? A protein dynamics force constant measured by neutron scattering. Science 288 5471 (2000) 1604-1607
104. Zhang L., Yang S., and Huang Y. Evidence for disaggregation of oligomeric G(o)alpha induced by guanosine-5;-3-O-(thio)triphosphate activation. Biochemistry (Mosc.) 68 1 (2003) 121-128
105. Zhu Y., King M.A., Schuller A.G.P., Nitsche J.F., Riedl M., Elde R.P., Unterwald E., Pasternak G.W., and Pintar J.E. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24 (1999) 243-252